Vr Adviser, LLC Annexon, Inc. Transaction History

Vr Adviser, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 15, 2023	BUY	$3.75 - $6.63 $4.84 Million - $8.56 Million	1,291,573 Added 66.97%	3,220,050 $19.3 Million
Q3 2022 Nov 14, 2022	BUY	$3.75 - $6.63 $4.84 Million - $8.56 Million	1,291,573 Added 66.97%	3,220,050 $19.9 Million
Q2 2022 May 15, 2023	SELL	$2.11 - $4.06 $2.73 Million - $5.24 Million	-1,291,573 Reduced 40.11%	1,928,477 $7.27 Million
Q2 2022 Aug 15, 2022	BUY	$2.11 - $4.06 $4.07 Million - $7.83 Million	1,928,477 New	1,928,477 $7.27 Million

158

102M

3.61M

1.08M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $312M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.